These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 9412538)

  • 41. Interaction between cardiac sympathetic drive and heart rate in heart failure: modulation by adrenergic receptor genotype.
    Kaye DM; Smirk B; Finch S; Williams C; Esler MD
    J Am Coll Cardiol; 2004 Nov; 44(10):2008-15. PubMed ID: 15542284
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sympathetic activation in congestive heart failure: reproducibility of neuroadrenergic markers.
    Grassi G; Bolla G; Quarti-Trevano F; Arenare F; Brambilla G; Mancia G
    Eur J Heart Fail; 2008 Dec; 10(12):1186-91. PubMed ID: 18851926
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Remodelling of cardiac sympathetic re-innervation with thoracic spinal cord stimulation improves left ventricular function in a porcine model of heart failure.
    Liao SY; Liu Y; Zuo M; Zhang Y; Yue W; Au KW; Lai WH; Wu Y; Shuto C; Chen P; Siu CW; Schwartz PJ; Tse HF
    Europace; 2015 Dec; 17(12):1875-83. PubMed ID: 25767085
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differences in norepinephrine levels in different vascular beds in congestive heart failure.
    Eichhorn EJ; Hatfield BA; Marcoux L
    Am J Cardiol; 1993 Feb; 71(5):442-6. PubMed ID: 8430636
    [No Abstract]   [Full Text] [Related]  

  • 45. Neuroprotective effects of testosterone upon cardiac sympathetic function in rats with induced heart failure.
    Han Y; Fu L; Sun W; Cao J; Xie R; Zhou P; Kang N; Sun J
    Eur J Pharmacol; 2009 Oct; 619(1-3):68-74. PubMed ID: 19665014
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nervous system control mechanisms in heart failure.
    Cohn JN
    Acta Med Scand Suppl; 1986; 707():15-20. PubMed ID: 2874690
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The 2009 Carl Ludwig Lecture: Pathophysiology of the human sympathetic nervous system in cardiovascular diseases: the transition from mechanisms to medical management.
    Esler M
    J Appl Physiol (1985); 2010 Feb; 108(2):227-37. PubMed ID: 19940096
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biochemical evidence of sympathetic hyperactivity in human hypertension.
    Esler M; Ferrier C; Lambert G; Eisenhofer G; Cox H; Jennings G
    Hypertension; 1991 Apr; 17(4 Suppl):III29-35. PubMed ID: 2013490
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of adrenergic blockade on plasma adrenomedullin concentration during static handgrip in patients with heart failure.
    Krzemiński K; Nazar K; Cybulski G; Mikulski T
    Clin Physiol Funct Imaging; 2006 Nov; 26(6):328-34. PubMed ID: 17042897
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Autonomic pathophysiology in heart failure patients. Sympathetic-cholinergic interrelations.
    Porter TR; Eckberg DL; Fritsch JM; Rea RF; Beightol LA; Schmedtje JF; Mohanty PK
    J Clin Invest; 1990 May; 85(5):1362-71. PubMed ID: 2332495
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sympathetic nervous system activation in human heart failure: clinical implications of an updated model.
    Floras JS
    J Am Coll Cardiol; 2009 Jul; 54(5):375-85. PubMed ID: 19628111
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sympathetic cardioneuropathy in dysautonomias.
    Goldstein DS; Holmes C; Cannon RO; Eisenhofer G; Kopin IJ
    N Engl J Med; 1997 Mar; 336(10):696-702. PubMed ID: 9041100
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Aging effects on human sympathetic neuronal function.
    Esler MD; Turner AG; Kaye DM; Thompson JM; Kingwell BA; Morris M; Lambert GW; Jennings GL; Cox HS; Seals DR
    Am J Physiol; 1995 Jan; 268(1 Pt 2):R278-85. PubMed ID: 7840332
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neuroendocrine activation in congestive heart failure.
    Forfar JC
    Am J Cardiol; 1991 May; 67(12):3C-5C. PubMed ID: 2021117
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Response of sympathetic nervous system activity to exercise in patients with congestive heart failure.
    Kinugawa T; Ogino K; Kitamura H; Miyakoda H; Saitoh M; Hasegawa J; Kotake H; Mashiba H
    Eur J Clin Invest; 1991 Oct; 21(5):542-7. PubMed ID: 1752293
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Heart rate modulation by sympathetic nerves in dogs with heart failure.
    Uechi M; Shimizu A; Mizuno M
    J Vet Med Sci; 2002 Nov; 64(11):1023-9. PubMed ID: 12499688
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Abnormal neurohumoral response to nitroprusside infusion in congestive heart failure.
    Olivari MT; Levine TB; Cohn JN
    J Am Coll Cardiol; 1983 Sep; 2(3):411-7. PubMed ID: 6875105
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Catecholamines and their blockade in congestive heart failure.
    White CM
    Am J Health Syst Pharm; 1998 Apr; 55(7):676-82. PubMed ID: 9558423
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Single-unit muscle sympathetic nervous activity and its relation to cardiac noradrenaline spillover.
    Lambert EA; Schlaich MP; Dawood T; Sari C; Chopra R; Barton DA; Kaye DM; Elam M; Esler MD; Lambert GW
    J Physiol; 2011 May; 589(Pt 10):2597-605. PubMed ID: 21486790
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The 2021 Carl Ludwig Lecture. Unsympathetic autonomic regulation in heart failure: patient-inspired insights.
    Floras JS
    Am J Physiol Regul Integr Comp Physiol; 2021 Sep; 321(3):R338-R351. PubMed ID: 34259047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.